VINEET SIDHU: Open Payments
NPI 1841700580 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 41 payments from 12 companies in 2025. Trend: 2023 $927 · 2024 $770 · 2025 $979
Food & beverage: $979
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $179 |
| AstraZeneca Pharmaceuticals LP | 5 | $160 |
| Novartis Pharmaceuticals Corporation | 11 | $157 |
| PFIZER INC. | 4 | $102 |
| Medtronic, Inc. | 1 | $97 |
| Amgen Inc. | 3 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
Products named: Kerendia, LEQVIO, VENASEAL, REPATHA, ELIQUIS, CAMZYOS, JARDIANCE, LifeVest.
Industry payments across MI — which companies pay providers there.
